MunaQayedMD
Pediatric Hematology & Oncology • Atlanta, GAAssistant Professor, Pediatrics, Emory University School of Medicine
Dr. Qayed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Emory UniversityMSc, Clinical Research, 2010
Children's Hospital of MichiganResidency, Pediatrics, 2004 - 2007
University of Jordan Faculty of MedicineClass of 2002
Certifications & Licensure
GA State Medical License 2007 - 2026
MI State Medical License 2004 - 2007
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors Start of enrollment: 2011 Apr 01
- Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2012 Dec 10
- Abatacept as GVHD Prophylaxis Phase 2
- Join now to see all
Publications & Presentations
PubMed
- Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...Seth J Rotz, Lori Wiener, K Scott Baker, Sung Won Choi, Rachel Phelan
Transplantation and Cellular Therapy. 2025-04-01 - Umbilical Cord Blood Reduced Relapse but Increased Nonrelapse Mortality Compared to Matched Unrelated Donor Transplantation in Pediatric Acute Myeloid Leukemia With Ac...Takuto Takahashi, Franziska Wachter, Francesca Alvarez Calderon, Malika Kapadia, Muna Qayed
Transplantation and Cellular Therapy. 2025-04-01 - Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy.Hannah Lust, Liora M Schultz, Soyang Kwon, Gregory W Roloff, Ibrahim Aldoss
Blood Advances. 2025-03-24
Journal Articles
- Genetic Mechanisms of Target Antigen Loss in CAR19 Therapy of Acute Lymphoblastic LeukemiaJohn E Levine, Muna Qayed, Stephan A Grupp, Eneida R Nemecek, Stella M Davies, Michael R Verneris, Michael Boyer, Jeffrey A Engelman, Nature
- Indoles Derived from Intestinal Microbiota Act via Type I Interferon Signaling to Limit Graft-Versus-Host-DiseaseEdmund K Waller, Zachariah DeFilipp, Muna Qayed, Akshay Sharma, Blood
Abstracts/Posters
- Transcriptomic Analysis of CD4+ T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28...Muna Qayed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous...Muna Qayed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseMuna Qayed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Peach Bowl Inc. Funds 5 New Research Projects at Children’s Healthcare of AtlantaNovember 2nd, 2022
- Woman Wants to Become a Nurse After Battling Leukemia as Teen, Overcoming OddsJune 4th, 2021
Arthritis Drug Cuts GVHD Risk in Stem Cell TransplantsJanuary 25th, 2021- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
